Determination of Cefepime and Related Compounds Using HPLC with UV Detection - - Chromatography Online
FindAnalytichem Custom Search
About Search
Determination of Cefepime and Related Compounds Using HPLC with UV Detection


The Application Notebook

Deanna Hurum, Brian De Borba and Jeff Rohrer, Dionex Corporation, Sunnyvale, California, USA.

Cephalosporins contain a four-member β-lactam ring that is inherently strained and prone to hydrolysis and photolysis, limiting stability and leading to degradation of products that may be toxic.1 In addition, synthetic byproducts are generated and persist during production of these antibiotics including cefepime. Analysis of cefepime purity is particularly challenging because of the presence of such isomeric synthetic impurities. The Acclaim 120 C18, 3 μm can be used to meet and exceed the criteria set by the USP for determining related substances and assaying the purity of cefepime.

Experimental


Figure 1
A Dionex UltiMate 3000 system with a DGP-3600M pump, an FLM-3100 flow manager (a TCC-3200 column compartment could be used) a WPS-3000T autosampler and a VWD-3400 detector was used in this work. An Acclaim 120 C18, 3 μm Analytical (2.1 × 150 mm) was used for all separations with a flow-rate of 0.20 mL/min. Analytes were detected by UV absorption at 254 nm. A 1 mL injection volume was used throughout. Chromeleon chromatography management software (Dionex) was used for system control and data processing.

Results and Discussion


Table 1
Because of the smaller column dimensions and the 3 μm particle size, the USP gradient method can be considerably shortened and still meet the USP requirements. Figure 1 illustrates the separation possible with a gradient method that removes 20 min from the run time for each injection. This shortened gradient meets the USP criteria for peak asymmetry, resolution between cefepime and cefepime related substances A and B, theoretical plates and capacity factor. The precision of this shortened gradient was tested with retention time RSDs of 0.06% or less and peak area RSDs of 0.82% or less (Table 1). Resolution is significantly improved, including the clear separation of an additional peak with a retention time of 9.39 min. This peak is not described in the current USP monograph, but it is recognized as impurity F in EP method 2126.

Conclusion

In this study, the Acclaim 120 C18 column, an HPLC L1 column with good steric selectivity, was successfully used for the determination of cefepime and cefepime related substances. The methods reduced the time needed for analysis by 40% and improved the resolution as compared to the current USP method. Additionally, the low flow-rates used in this method save time and resources spent on mobile phase preparation and reduce waste production.

Reference

1. S.M. Rabouan-Guyon et al., Int. J. Pharm., 154, 185–190 (1997).




Acclaim, Chromeleon, and UltiMate are registered trademarks of Dionex Corporation.

Dionex Corporation
1228 Titan Way, PO Box 3603, Sunnyvale, California 94088-3603, USA
te. +1 408 737 0700 fax +1 408 730 9403
Website: http://www.dionex.com/

ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All Comments submitted are subject to review, and may be delayed before posting. Comments will be posted at the discretion of the editor.
LCGC E-mail Newsletters
Select each newsletter you wish to subscribe for:
Monthly
| Weekly
| Monthly
more info
Survey
How long does it take for your laboratory to validate a CDS system?
0-3 months
3-6 months
6-9 months
9-12 months
12-18 months
>18 months
0-3 months
44%
3-6 months
22%
6-9 months
11%
9-12 months
0%
12-18 months
22%
>18 months
0%
View Results
Source: The Application Notebook,
Click here